WallStreetZenWallStreetZen

NASDAQ: OCX
Oncocyte Corp Stock Ownership - Who owns Oncocyte?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Oncocyte Corp insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Andrew ArnoDirector2024-04-1133,898$2.95
$100.00kBuy
Broadwood Partners LP10% Owner2024-04-112,420,000$2.92
$7.06MBuy
Josh RiggsCEO and President2024-04-113,390$2.95
$10.00kBuy
Alfred D. KingsleyDirector2023-06-1430,000$0.22
$6.45kBuy

1 of 1

OCX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OCX insiders and whales buy or sell their stock.

OCX Shareholders

What type of owners hold Oncocyte Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Pura Vida Investments LLC422.13%34,922,779$86.61MInsider
Broadwood Partners LP237.46%19,645,427$48.72MInsider
Lineage Cell Therapeutics Inc73.02%6,041,154$14.98MInsider
John Peter Gutfreund59.23%4,900,047$12.15MInsider
George Karfunkel44.24%3,659,860$9.08MInsider
Broadwood Capital Inc30.33%2,509,066$6.22MInstitution
Awm Investment Company Inc9.12%754,286$1.87MInstitution
Alfred D. Kingsley7.28%601,990$1.49MInsider
Pura Vida Investments LLC7.09%586,930$1.46MInstitution
Ronald Asbury Andrews7.05%583,212$1.45MInsider

1 of 3

OCX vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OCX5.82%94.18%Net BuyingNet Buying
DMTK15.75%77.74%Net SellingNet Selling
MYNZ1.10%0.00%
XGN36.96%63.04%Net SellingNet Selling
TTOO0.51%99.49%Net Selling
View Top Diagnostic & Research Stocks

Oncocyte Stock Ownership FAQ

Who owns Oncocyte?

Oncocyte (NASDAQ: OCX) is owned by 53.79% institutional shareholders, 870.26% Oncocyte insiders, and 0.00% retail investors. Pura Vida Investments LLC is the largest individual Oncocyte shareholder, owning 34.92M shares representing 422.13% of the company. Pura Vida Investments LLC's Oncocyte shares are currently valued at $86.61M.

If you're new to stock investing, here's how to buy Oncocyte stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.